In Vitro and In Vivo Diagnostic Substances: average industry financial ratios for U.S. listed companies

Industry: 2835 - In Vitro and In Vivo Diagnostic Substances     Measure of center:

Financial ratio Year
2021 2020 2019 2018 2017 2016
Solvency Ratios
Debt ratio 0.27 0.30 0.29 0.33 0.32 0.53
Debt-to-equity ratio 0.36 0.39 0.32 0.37 0.34 0.12
Interest coverage ratio -7.26 -73.03 -5.55 -3.35 -2.75 -2.06
Liquidity Ratios
Current Ratio 4.65 3.39 4.86 3.51 3.05 2.46
Quick Ratio 3.36 2.79 4.17 2.86 2.50 2.08
Cash Ratio 3.59 2.85 3.96 1.52 1.86 1.83
Profitability Ratios
Profit margin -204.8% -138.3% -120.2% -80.6% -17.4% -26%
ROE (Return on equity), after tax -52.9% -46.2% -48.9% -134.6% -93.9% -68.6%
ROA (Return on assets) -41% -35.6% -36% -66.9% -41.6% -41.8%
Gross margin 44.5% 45.5% 56.7% 47.8% 56.2% 54.9%
Operating margin (Return on sales) -11.7% -6.7% -5.4% -4.9% -2.1% 2.9%
Activity Ratios
Asset turnover (days) 1356 1315 1169 1122 806 754
Receivables turnover (days) 50 47 48 53 50 49
Inventory turnover (days) 110 103 133 166 141 133
Price Ratios
Dividend Payout Ratio - - 0.28 0.41 0.11 0.14

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: